Introduction {#s1}
============

MicroRNAs (miRNAs) form a growing class of endogenous non-coding RNA molecules that modulate gene expression post-transcriptionally. Like transcription factors, an increase in the number of miRNAs strongly correlates with greater organismal complexity [@pone.0060480-Martinez1]. miRNAs form elaborate and sophisticated regulatory networks, where a given miRNA can influence the stability or translatability of hundreds of mRNA targets [@pone.0060480-Miranda1], and numerous miRNAs can act in concert to repress a common target. While transcription factors act as "switches" to initiate broad developmental transitions, miRNAs may act downstream to fine-tune genetic regulatory programs. An influential model posits that highly expressed miRNAs act to quell the deleterious effects of leaky transcription, while moderately expressed miRNAs buffer fluctuations in expression at weak or suboptimal promoters [@pone.0060480-Hornstein1].

Generation of cellular diversity during mammalian brain development requires precise coordination of gene regulatory networks, with integral involvement of miRNAs. Lineage-specific expression signatures of cultured astrocytes and neurons [@pone.0060480-Smirnova1] implicate miRNAs in neural cell fate specification. Neurobiological functions have been attributed to specific miRNAs. For example, miR-124 promotes neuronal differentiation [@pone.0060480-Makeyev1], and miR-134 is involved in dendritic branching [@pone.0060480-Schratt1]. Global ablation of miRNAs is achieved in model systems by knocking out the essential miRNA processing enzyme, Dicer. In zebrafish, maternal zygotic Dicer knockout embryos undergo axis formation and body patterning, but exhibit profound defects in brain morphogenesis [@pone.0060480-Giraldez1]. Likewise, selective inactivation of Dicer produces morphogenetic CNS abnormalities in conditional knockout mice, including microcephaly and reduced elaboration of dendritic branches [@pone.0060480-Davis1]. While neuronal progenitors remain viable in the absence of miRNAs, cytoarchitectural abnormalities arise from failures to differentiate and propagate newborn neurons [@pone.0060480-DePietriTonelli1]. Dysregulation of miRNAs has been implicated in the etiology of schizophrenia [@pone.0060480-Hansen1], [@pone.0060480-Kocerha1], [@pone.0060480-Beveridge1], [@pone.0060480-Perkins1], as well as age-related neurodegenerative disorders [@pone.0060480-Hebert1], [@pone.0060480-Lukiw1], [@pone.0060480-Schaefer1].

Early expression studies uncovered a subset of brain-specific or brain-enriched miRNAs [@pone.0060480-Sempere1]. Molecular profiling studies in rodents showed that miRNAs are dynamically regulated during brain development [@pone.0060480-Krichevsky1], with a "chronological wave" of sequentially expressed miRNA classes [@pone.0060480-Miska1]. Since these landmark studies, hundreds of additional miRNAs have been discovered, including many that are specific to humans. In the present study, we have performed comprehensive miRNA expression analysis in human postmortem brain samples representing fetal, early postnatal, and adult time points. We measured the expression of all known miRNAs (miRBase 10.0), as well as 373 novel, putative miRNAs. Classifying miRNAs based on temporal expression profiles may provide insight into their regulation and potential neurobiological functions.

Methods {#s2}
=======

Sample selection and preparation {#s2a}
--------------------------------

Frozen brain tissue samples were obtained from the NICHD Brain and Tissue Bank for Developmental Disorders, housed at the University of Maryland. Brain sectioning (described at <http://medschool.umaryland.edu/btbank/NICHD-BTB-ProtocolMethods.asp>) began with separation of the cerebral hemispheres, followed by removal of the midbrain/pons/cerebellum. The remaining cerebrum (from the left hemisphere) was sectioned coronally at approximately 1 cm intervals. A total of 48 frozen cerebral tissue samples were obtained. Fetal samples originated from subjects ranging in gestational age from 14 weeks to 24 weeks. Additional tissue samples were obtained to represent early postnatal time points. The majority of tissue samples originated from African American individuals ([**Table 1**](#pone-0060480-t001){ref-type="table"}). Three samples were excluded from microarray expression analysis, two due to poor RNA integrity measures and one due to uncertain sample identification. All remaining samples had RNA integrity measures \>7. The adult time point is represented by two commercially available total RNA products. FirstChoice Human Brain Total RNA (Ambion) is a high-quality RNA sample derived from an 81 year old adult male, and FirstChoice Human Brain Reference RNA (Ambion) is pooled from twenty-three male and female Caucasian donors with an average age of 68.
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###### Demographic information of brain tissue donors.

![](pone.0060480.t001){#pone-0060480-t001-1}

  UMB\#     GA weeks   Years   Days   Pool     Sex               Race             PMI (hrs)
  -------- ---------- ------- ------ ------ --------- -------------------------- -----------
  4912         14                      1     female    African AmerincaAmerican       1
  4799         14                      1      male         African American           3
  4794         14                      1      male         African American           1
  4934         16                      2      male         African American           2
  4573         16                      2     female        African American           1
  1388         16                      2      male         African American           1
  396          16                      2      male         African American           1
  249          17                      3      male         African American           1
  12           17                      3      male         African American           1
  43           17                      3     female        African American           1
  57           18                      4     female        African American           1
  42           18                      4     female        African American           1
  33           18                      4     female        African American           1
  31           18                      4      male         African American           1
  14           18                      4     female        African American           3
  4825         18                      4      male         African American           1
  4823         18                      4      male         African American           4
  113          18                      4     female        African American           1
  201          18                      4      male         African American           1
  278          18                      4      male         African American           1
  279          18                      4     female        African American           1
  1521         18                      4     female        African American           1
  280          18                      4     female        African American           2
  291          18                      4      male         African American          12
  391          18                      4      male            Caucasian               1
  392          19                      5      male         African American           1
  4609         19                      5     female        African American           2
  261          19                      5      male         African American           1
  250          19                      5      male         African American           1
  66           19                      5     female        African American           3
  9            19                      5     female        African American           2
  46           19                      5     female           Caucasian              12
  4889         19                      5      male         African American           2
  4715         20                      6      male         African American           4
  4654         20                      6     unknown       African American           2
  45           20                      6      male         African American           2
  \*311        24                            female           Caucasian               1
  779                    0      5      7      male         African American           5
  \*633                  0      60            male         African American          21
  1055                   0      96     7      male            Caucasian              12
  \*1742                 0      89           female        African American          24
  1296                   0      98     7      male         African American          16
  1453                   1      78     8      male         African American          19
  1063                   1     123     8      male         African American          21
  1488                   1     137     8      male         African American          21
  1499                   4     170     9     female             Asian                21
  4670                   4     273     9      male            Caucasian              17
  1185                   4     258     9      male            Caucasian              17

samples excluded from expression analysis.

UMB\# -- Sample identifier, NICHD Brain and Tissues Bank for Developmental Disorders.

GA -- gestational age.

Pool -- indicates sample pooling for TaqMan arrays.

PMI -- post-mortem interval (hours).

Tissue homogenization and RNA extraction procedures were performed using the *mir*Vana PARIS kit (Ambion) according to the manufacturer\'s protocol. RNA yield and quality were determined using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA) and Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).

Microarray preparation, data acquisition, and analysis {#s2b}
------------------------------------------------------

Dual-channel microarray expression analysis was performed using the NCode Human miRNA Microarray V3 (Invitrogen, Carlsbad, CA), which contains 710 probes for validated human miRNAs from miRBase release 10.0 as well as 373 Invitrogen novel human miRNAs. On each array, a single Cy3 labeled total RNA sample was competitively hybridized against a Cy5 labeled control pool. The control pool was a mixture of all RNA samples, where each developmental time point was equally represented, and each individual sample was equally represented within a given time point. For each channel, 1 μg of total RNA was labeled with the *Label* IT® miRNA Labeling Kit, Version 2 (Mirus Bio, Madison, WI) according to manufacturer\'s protocol. Samples were hybridized to the array at 37°C overnight using the hybridization buffer included with the labeling kit.

Image analysis was performed on a GenePix 4000B microarray scanner. A marked difference in pixel intensity was observed between Sanger miRNAs and the novel features exclusively present on the NCode V3 arrays, with many of the latter approaching saturation. Photomultiplier tube (PMT) settings were adjusted so as to balance signal intensity in the red and green channels, and maximize pixel intensity without saturation at 10% power. Arrays were then rescanned at 100% power without PMT adjustment. The 10% and 100% scan data were subsequently merged using methods outlined in **Methods S1 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**, which resulted in substantial improvements in data quantity and quality. Images were exported and processed using the Acuity 4.0 software package. Microarray data has been deposited in the Gene Expression Omnibus (GEO) database under accession number GSE45126. Data filtering parameters were established to include only features with (1) at least 70% of pixels greater than 2 standard deviations above background in either the red or green channel, (2) regression R^2^ greater than 0.5 to ensure feature uniformity, (3) less than 20% of pixels saturated in both the red and the green channels, and (4) no flags upon visual inspection. Normalization was performed with the LOWESS (locally weighted regression) method, and expression log ratios were used for statistical analysis. Merging and filtering resulted in a final set of 464 genes. Prior to significance testing, distribution assumption checks were performed, as outlined in **Methods S2 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**.

464 genes which passed the filtering criteria were analyzed using ANOVA (analysis of variance) and backward model selection, and genes whose expression differed between any subset of the fetal, young, and adult time points were identified (method described in more detail in **Methods S3 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**). A simulation based false discovery rate (FDR) estimation similar to the SAM procedure [@pone.0060480-Tusher1] was used to adjust for multiple testing. 2500 simulated datasets were used, and it was found that a p-value of 0.001901 controled for the FDR at a rate of 1%.

Preparation of TaqMan miRNA arrays {#s2c}
----------------------------------

Sample pools for each unique developmental age were constructed by combining equal amounts of extracted total RNA (samples used in pools indicated in [**Table 1**](#pone-0060480-t001){ref-type="table"}). Reverse transcription reactions were performed using 600ng total RNA input and reagents from the TaqMan miRNA Reverse Transcription Kit and Megaplex Primer Pools (Applied Biosystems). Reactions were performed (without preamplification) according to the Megaplex Pools protocol (Applied Biosystems, Carlsbad, CA), and thermal cycling was performed in a PTC-200 DNA Engine (MJ Research). Real-time PCR reactions were performed using the TaqMan Human miRNA Array set v2.0 in a 7900HT real-time PCR system (Applied Biosystems, Carlsbad, CA). A single array set was run for each sample pool.

Analysis of TaqMan miRNA arrays {#s2d}
-------------------------------

Relative expression analysis was performed using the SDS 2.3 software. Using the 2^−ΔΔCt^ method [@pone.0060480-Livak1], expression levels of all miRNAs were normalized to the geometric mean of RNU44 and RNU48 snoRNAs and mammalian U6 snRNA. A stringent threshold was set to exclude miRNAs which did not show robust expression in at least one time point. This threshold was arbitrary, and corresponded to a raw Ct of \>29 at all time points. Next, the fold change in expression was calculated relative to the 14 week time point in order to identify miRNAs with differential expression within the prenatal time points. Similar analysis was performed, using the 5--98 day time point as a reference, for the postnatal time points. Additionally, the 14 week time point was used as a reference to calculate fold-changes at all prenatal and postnatal time points. The distribution of these fold changes was used to identify miRNAs that exceeded two standard deviation fold change at any given time point. Only mature, guide-strand derived, miRNAs were included in these analyses.

Results {#s3}
=======

MicroRNA expression analysis was performed using the NCode Human miRNA microarray (Invitrogen), which contains 710 probes for validated human miRNAs from miRBase release 10.0, as well as 373 Invitrogen novel human miRNAs. After filtering, the final data set consisted of 464 genes which could be assessed for differential expression between the time points. 312 had significantly different expression between at least two of the sample types, broadly defined as fetal, young and adult. Developmental expression patterns for these 312 miRNAs were analyzed using correlation-based hierarchical clustering ([**Figure 1**](#pone-0060480-g001){ref-type="fig"}). Samples from developmentally proximal time points had more similar miRNA expression signatures, suggesting that a global miRNA expression profile can act as a marker of developmental stage. Of the 312 significant genes; (a) 81 genes correspond to the case where F≠Y = A, i.e., the fetal mean expression is significantly different from young and adult; (b) 101 genes correspond to the case where F = Y≠A; (c) 60 genes correspond to the case where F = A≠Y; and (d) 70 genes correspond to the case where all mean expression levels differ (F≠Y≠A).

![Hierarchical clustering of all significant miRNAs.\
Hierarchical clustering was performed on 312 differentially expressed miRNAs using a correlation metric. Included miRNAs have significantly different expression levels in at least one pair-wise comparison between the general sample types fetal, young and adult. The sample types are indicated in the colored bar (blue-fetal, red-young, green-adult).](pone.0060480.g001){#pone-0060480-g001}

Model classes were refined to take into account the direction of expression differences between sample types, resulting in 13 unique model classes ([**Table 2**](#pone-0060480-t002){ref-type="table"}). Model classes 1 and 2 are models for which the young and adult mean expression levels coincide, and the fetal mean expression differs. A substantially greater number of miRNAs belong to the class where fetal expression levels are lower than that of young and adult samples (60 miRNAs versus 14 that show higher relative expression). Model classes 1 and 7, marked by lowest expression at fetal time points, appear to be particularly enriched for novel miRNAs. Re-sampling via permutation of age category labels confirmed that this enrichment for novel miRNAs is significant (p = 0.0015 for class 1, p = 0.0393 for class 7). For model classes where the fetal and young mean expression levels coincide and adult expression differs, there is a more balanced split between down-regulation and up-regulation (model classes 3 and 4 with 41 and 60 genes, respectively). The same is also true when fetal and adult expression levels coincide, with the young being different (model classes 5 and 6 with 33 and 27 genes, respectively). Subsequent experiments investigated distinct RNA fractions to gain insight into the Invitrogen novel content (**Methods** **S4 and Figure S1 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**), and those features suspected of being larger than 200 bp are indicated in [**Table 2**](#pone-0060480-t002){ref-type="table"}.

10.1371/journal.pone.0060480.t002

###### Classifying miRNAs based on developmental expression profiles.
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  Class 1: F\<Y = A          Class 2: F\>Y = A       Class 3: F = Y\<A      Class 4: F = Y\>A      Class 5: F = A\<Y
  ----------------------- ----------------------- ----------------------- --------------------- -----------------------
  hsa-miR-138                   hsa-miR-17              hsa-let-7e           hsa-miR-125a-3p         hsa-miR-187\*
  hsa-miR-382                   hsa-miR-185             hsa-let-7f           hsa-miR-142-5p          hsa-miR-220b
  IVGN-novel-miR_3301          hsa-miR-516b             hsa-miR-103           hsa-miR-150\*         hsa-miR-30c-1\*
  IVGN-novel-miR_3311         hsa-miR-654-5p            hsa-miR-107          hsa-miR-193b\*           hsa-miR-425
  IVGN-novel-miR_3313       IVGN-novel-miR_3408       hsa-miR-125a-5p          hsa-miR-198          hsa-miR-491-5p
  IVGN-novel-miR_3314       IVGN-novel-miR_3456        hsa-miR-181c            hsa-miR-214            hsa-miR-612
  IVGN-novel-miR_3318       IVGN-novel-miR_3493         hsa-miR-24            hsa-miR-23a\*           hsa-miR-617
  IVGN-novel-miR_3321       IVGN-novel-miR_3558         hsa-miR-26a          hsa-miR-296-3p         hsa-miR-628-3p
  IVGN-novel-miR_3326       IVGN-novel-miR_3644         hsa-miR-29a            hsa-miR-298            hsa-miR-665
  IVGN-novel-miR_3327       IVGN-novel-miR_3646         hsa-miR-30d           hsa-miR-30b\*           hsa-miR-744
  IVGN-novel-miR_3346 X     IVGN-novel-miR_3652         hsa-miR-373            hsa-miR-370           hsa-miR-92b\*
  IVGN-novel-miR_3351       IVGN-novel-miR_3654       hsa-miR-491-3p          hsa-miR-373\*       IVGN-novel-miR_3309
  IVGN-novel-miR_3356       IVGN-novel-miR_3683         hsa-miR-497           hsa-miR-422a        IVGN-novel-miR_3315
  IVGN-novel-miR_3383                                   hsa-miR-646          hsa-miR-485-5p       IVGN-novel-miR_3385
  IVGN-novel-miR_3384                                 hsa-miR-768-3p         hsa-miR-486-3p      IVGN-novel-miR_3386 X
  IVGN-novel-miR_3387 X         hsa-miR-98            hsa-miR-518c\*       IVGN-novel-miR_3429  
  IVGN-novel-miR_3390 X    IVGN-novel-miR_3306 X      hsa-miR-548c-5p      IVGN-novel-miR_3433  
  IVGN-novel-miR_3394 X    IVGN-novel-miR_3310 X        hsa-miR-564        IVGN-novel-miR_3435  
  IVGN-novel-miR_3397                              IVGN-novel-miR_3316 X       hsa-miR-608        IVGN-novel-miR_3436
  IVGN-novel-miR_3399 X    IVGN-novel-miR_3322 X        hsa-miR-610        IVGN-novel-miR_3437  
  IVGN-novel-miR_3401                               IVGN-novel-miR_3332        hsa-miR-616        IVGN-novel-miR_3453
  IVGN-novel-miR_3402                               IVGN-novel-miR_3341        hsa-miR-630        IVGN-novel-miR_3463
  IVGN-novel-miR_3403                              IVGN-novel-miR_3354 X       hsa-miR-650        IVGN-novel-miR_3468
  IVGN-novel-miR_3410 X                             IVGN-novel-miR_3355        hsa-miR-659        IVGN-novel-miR_3474
  IVGN-novel-miR_3411                              IVGN-novel-miR_3391 X     hsa-miR-671-5p       IVGN-novel-miR_3515
  IVGN-novel-miR_3412 X                             IVGN-novel-miR_3422        hsa-miR-674        IVGN-novel-miR_3537
  IVGN-novel-miR_3415                               IVGN-novel-miR_3428        hsa-miR-760        IVGN-novel-miR_3538
  IVGN-novel-miR_3418                               IVGN-novel-miR_3460        hsa-miR-933        IVGN-novel-miR_3559
  IVGN-novel-miR_3423                               IVGN-novel-miR_3502    IVGN-novel-miR_3328    IVGN-novel-miR_3579
  IVGN-novel-miR_3424                               IVGN-novel-miR_3504    IVGN-novel-miR_3329    IVGN-novel-miR_3593
  IVGN-novel-miR_3438 X     IVGN-novel-miR_3525     IVGN-novel-miR_3359    IVGN-novel-miR_3694  
  IVGN-novel-miR_3458                               IVGN-novel-miR_3541    IVGN-novel-miR_3361    IVGN-novel-miR_3695
  IVGN-novel-miR_3461                               IVGN-novel-miR_3560    IVGN-novel-miR_3377  
  IVGN-novel-miR_3465                               IVGN-novel-miR_3570    IVGN-novel-miR_3378  
  IVGN-novel-miR_3485                              IVGN-novel-miR_3573 X   IVGN-novel-miR_3400  
  IVGN-novel-miR_3486                               IVGN-novel-miR_3614    IVGN-novel-miR_3425  
  IVGN-novel-miR_3495                               IVGN-novel-miR_3624    IVGN-novel-miR_3434  
  IVGN-novel-miR_3497                               IVGN-novel-miR_3628    IVGN-novel-miR_3452  
  IVGN-novel-miR_3503                               IVGN-novel-miR_3650    IVGN-novel-miR_3466  
  IVGN-novel-miR_3520                              IVGN-novel-miR_3672 X   IVGN-novel-miR_3467  
  IVGN-novel-miR_3535 X                             IVGN-novel-miR_3673    IVGN-novel-miR_3470  
  IVGN-novel-miR_3543                                                      IVGN-novel-miR_3471  
  IVGN-novel-miR_3548                                                      IVGN-novel-miR_3507  
  IVGN-novel-miR_3550 X                                                    IVGN-novel-miR_3516  
  IVGN-novel-miR_3552                                                      IVGN-novel-miR_3522  
  IVGN-novel-miR_3553 X                                                    IVGN-novel-miR_3526  
  IVGN-novel-miR_3556                                                      IVGN-novel-miR_3527  
  IVGN-novel-miR_3557                                                      IVGN-novel-miR_3536  
  IVGN-novel-miR_3563                                                      IVGN-novel-miR_3549  
  IVGN-novel-miR_3564                                                      IVGN-novel-miR_3586  
  IVGN-novel-miR_3566 X                             IVGN-novel-miR_3591                         
  IVGN-novel-miR_3568 X                             IVGN-novel-miR_3604                         
  IVGN-novel-miR_3582                                                      IVGN-novel-miR_3606  
  IVGN-novel-miR_3583                                                      IVGN-novel-miR_3649  
  IVGN-novel-miR_3595                                                      IVGN-novel-miR_3651  
  IVGN-novel-miR_3599                                                      IVGN-novel-miR_3668  
  IVGN-novel-miR_3607 X                             IVGN-novel-miR_3688                         
  IVGN-novel-miR_3626                                                                           
  IVGN-novel-miR_3657                                                                           
  IVGN-novel-miR_3659                                                                           
  IVGN-novel-miR_3679                                                                           
  IVGN-novel-miR_3680                                                                           
  IVGN-novel-miR_3681                                                                           
  IVGN-novel-miR_3682 X                                                                         
  IVGN-novel-miR_3697 X                                                                         
  IVGN-novel-miR_3698 X                                                                         
  IVGN-novel-miR_3699 X                                                                         

  Class 6: F = A\>Y       Class 7: F\<Y\<A      Class 9: Y\>F\>A      Class 10: F\>Y\>A      Class 12: Y\<F\<A
  --------------------- --------------------- --------------------- --------------------- -----------------------
  hsa-miR-106a               hsa-miR-22          hsa-miR-129-5p         hsa-miR-505\*           hsa-let-7a
  hsa-miR-106b           IVGN-novel-miR_3353      hsa-miR-185\*          hsa-miR-550            hsa-let-7b
  hsa-miR-124            IVGN-novel-miR_3357     hsa-miR-193a-5p       hsa-miR-551b\*           hsa-let-7c
  hsa-miR-125b           IVGN-novel-miR_3413      hsa-miR-194\*          hsa-miR-920            hsa-let-7d
  hsa-miR-181a           IVGN-novel-miR_3454       hsa-miR-202       IVGN-novel-miR_3335        hsa-let-7g
  hsa-miR-181b           IVGN-novel-miR_3489       hsa-miR-215                                  hsa-let-7i
  hsa-miR-206            IVGN-novel-miR_3542      hsa-miR-25\*                                  hsa-miR-10b
  hsa-miR-20a            IVGN-novel-miR_3551     hsa-miR-30c-2\*                                hsa-miR-16
  hsa-miR-28-5p          IVGN-novel-miR_3580     hsa-miR-371-5p                                 hsa-miR-195
  hsa-miR-297            IVGN-novel-miR_3666      hsa-miR-449b                                hsa-miR-330-3p
  hsa-miR-541\*                                    hsa-miR-498                               hsa-miR-574-5p X
  hsa-miR-9                                        hsa-miR-557                                hsa-miR-768-5p
  hsa-miR-93                                       hsa-miR-602                              IVGN-novel-miR_3302
  IVGN-novel-miR_3303                              hsa-miR-637                              IVGN-novel-miR_3379
  IVGN-novel-miR_3388                              hsa-miR-638                              IVGN-novel-miR_3395
  IVGN-novel-miR_3409                              hsa-miR-663                              IVGN-novel-miR_3439
  IVGN-novel-miR_3440                              hsa-miR-675                              IVGN-novel-miR_3490
  IVGN-novel-miR_3491                            hsa-miR-885-3p                             IVGN-novel-miR_3501
  IVGN-novel-miR_3505                            hsa-miR-886-5p                             IVGN-novel-miR_3615
  IVGN-novel-miR_3506                              hsa-miR-939                              IVGN-novel-miR_3616
  IVGN-novel-miR_3508                          IVGN-novel-miR_3476                          IVGN-novel-miR_3617
  IVGN-novel-miR_3528                          IVGN-novel-miR_3545                          IVGN-novel-miR_3618
  IVGN-novel-miR_3544                          IVGN-novel-miR_3546                          IVGN-novel-miR_3619
  IVGN-novel-miR_3561                          IVGN-novel-miR_3547                          IVGN-novel-miR_3627
  IVGN-novel-miR_3660                          IVGN-novel-miR_3603                          IVGN-novel-miR_3632
  IVGN-novel-miR_3662                          IVGN-novel-miR_3700                         IVGN-novel-miR_3639 X
  IVGN-novel-miR_3663                                                                       IVGN-novel-miR_3647

X-flagged as potentially being a larger ncRNA based on profiling of distinct RNA size fractions, as described in Methods S4 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}.

Analysis of microarray data from fetal samples alone was performed to determine if the gestational age (in weeks) had a significant impact on expression. After adjusting for multiple testing it was found that there were no miRNAs with significant changes in expression during the fetal time period. This may be due, in part, to the small sample sizes representing each developmental time point or to the lack of sensitivity and limited dynamic range of glass-slide microarrays. Similarly, an analysis was run on the young samples alone to determine if age (in days) had a significant impact on miRNA expression. After adjusting for multiple testing, there were no miRNAs with significant changes in expression.

Samples comprising each distinct time point were mixed to form 10 sample pools ([**Table 1**](#pone-0060480-t001){ref-type="table"}), and further miRNA expression analysis was performed using the TaqMan® MicroRNA Array v2.0. Many of the validated, Sanger miRNAs that were detected and quantified on TaqMan arrays fell below the threshold of detection on the NCode microarrays. Therefore the TaqMan data only partially validated the NCode array data, but also allowed for analysis of other miRNAs and for more refined analysis of expression changes within the pre- and post-natal time points. All raw real-time qPCR data is presented in **Table S1 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**.

The numbers of miRNAs with particular expression fold changes between groups are presented in [**Table 3**](#pone-0060480-t003){ref-type="table"}. Similar to what was observed in the microarray data set, these data demonstrate that global miRNA expression is lower in fetal than young and adult brain tissue, given the greater number of miRNAs with decreased fold change in the fetal versus young and adult samples. Although pooling of samples precludes a wide-range of formal statistical analyses, we sought to identify meaningful patterns of change within the pre- and post-natal time points. MiRNAs which show peaks of expression at a particular gestational or post-gestational time point may be viable candidate miRNAs involved in specific developmental processes. A Q--Q plot of fold changes for all miRNAs at all time points (see **Figure S2 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**) revealed expected trends. After setting an arbitrary threshold to exclude miRNAs that did not show high expression in at least one time point, the standard deviations for fold changes were calculated. In analysis of pre-natal time points, miRNAs were identified which showed a \>2 standard deviation fold change at any time point (relative to the 14 week time point) resulting in a list of 14 miRNAs (**Table S2 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**). Particular candidate miRNAs emerge from this analysis. For example, hsa-mir-449a/449b show a dramatic change in expression during 14--20 week gestation, with a peak at week 17. Another pattern is represented by 216b, which shows highest expression at week 14, then decreasing expression until it reaches a low at week 17, followed by increasing expression through weeks 18, 19, and 20. This trend for increasing expression does not extend into post-gestational timepoints, where expression is negligible.

10.1371/journal.pone.0060480.t003

###### Temporal expression analysis using real-time quantitative PCR.
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  Fold Increase    Fetal vs. Adult   Young vs. Adult   Fetal vs. Young   Fold Decrease   Fetal vs. Adult   Young vs. Adult   Fetal vs. Young
  --------------- ----------------- ----------------- ----------------- --------------- ----------------- ----------------- -----------------
  **\>2**                145               188               90             **\>2**            253               113               267
  **\>5**                92                85                47             **\>5**            136               63                130
  **\>10**               68                48                27            **\>10**            87                49                74
  **\>100**              23                23                 2            **\>100**           21                10                 7

The number of miRNAs that exceed the indicated fold difference are tabulated for each pair-wise sample type comparison.

In the individual analysis of post-natal time points, the earliest time point (5--98 days) served as the reference against the 1.5 and 4.5 year time point. Again, miRNAs with \>2 SD fold change from 5--98 day time point were identified, resulting in a list of 15 miRNAs (**Table S3 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**). Particular miRNAs show clear patterns of change during early childhood. For example, hsa-mir-135b shows dramatically decreasing expression during early childhood, while at prenatal time points hsa-mir-135b showed much higher but somewhat consistent expression. Mir-542-5p on the other hand, shows consistently low expression at prenatal time points, spikes at earliest childhood time point, then declines.

Examination of the pre- and postnatal time points collectively, using 14 week as reference time point, revealed 56 miRNAs with \>2 SD fold change between pre- and postnatal samples (**Table S4 in [File S1](#pone.0060480.s001){ref-type="supplementary-material"}**). This larger list is a reflection of the more robust collective differences in miRNA expression between fetal stages and early childhood, as compared to the more subtle changes within the fetal and early childhood periods. This analysis reveals interesting candidates, including the mir-17-92 cluster located on chromosome 13, and the paralogue clusters on chromosome 7 (mir-25/93/106b) and the X chromosome (mir-106a/18b/20b). Collectively, this miRNA family shows a trend for modestly decreasing expression at prenatal time points, and dramatically lower and decreasing expression at postnatal time points. In contrast, mir-132 displays modest and steady expression levels during prenatal time points, with a striking increase in expression during early childhood.

Discussion {#s4}
==========

We reported 312 out of 464 detected features with temporally distinct expression patterns in the cerebrum using microarray technologies. Additionally, we presented comprehensive miRNA expression profiles of pooled samples at each time point using TaqMan technology. Utilizing the microarray data, we found that differentially expressed species formed ten unique model classes with contrasting fetal, young, and adult expression profiles. Notably, many miRNAs fit a model that did not depict a consistent trend in expression along the fetal to adult timeline, but instead sharply increased or decreased at early postnatal stages. For example, the ubiquitously expressed let-7 family members are conserved from nematodes to primates, and are well-known markers of a terminally differentiated state [@pone.0060480-Peter1], [@pone.0060480-Roush1], [@pone.0060480-Johnson1]. In our study, expression levels of most let-7 family members dramatically peaked at the adult time point, as expected, but we also observed a surprising decline in expression at early postnatal stages relative to fetal. We would also like to draw attention to several miRNAs with well-characterized roles in CNS development. miR-124 and miR-9 are brain-specific miRNAs [@pone.0060480-Landgraf1] that are highly up-regulated at the onset of embryonic neurogenesis. Over-expression of these miRNAs in cultured cells promotes adaptation of a neuronal fate, while down-regulation has the opposite effect [@pone.0060480-Krichevsky2]. Developmental expression profiling of the murine CNS revealed 12 miRNAs (miR-9, miR-17-5p, miR-124a, miR-125a, miR-125b, miR-130a, miR-140, miR-181a, miR-199a, miR-205, miR-214, miR-301) with significantly higher expression at embryonic versus postnatal time points. Expression profiling was not performed in the fully mature mouse. In the present study, 4 miRNAs (miR-9, miR-124, miR-125b, miR-181a) fit the model F = A\>Y. The decrease in expression at early postnatal stages is consistent with observations in the mouse; however, expression levels appear to rebound in the adult human brain. It is intriguing to note that, with regard to several neuronal miRNAs as well as the let-7 family, the early postnatal brain appears to adopt a more immature, dedifferentiated state. However, we did not observe expression of the pluripotency markers miR-290, -295, -293, -294, or the -302 family [@pone.0060480-Strauss1] at any developmental time point. With the exception of certain neurogenic brain regions, such as the dentate gyrus of the hippocampus [@pone.0060480-Balu1], neurogenesis is mostly complete by the 18^th^ week of gestation. Our data support a role for miRNAs in later stages of neuronal development, such as the formation and pruning of synapses [@pone.0060480-Fiore1], which continues throughout infancy and early childhood. At these developmental stages, we observe transient down-regulation of several well-characterized neuronal miRNAs, with concomitant spikes in expression of 31 other Sanger miRNAs (model classes 5 and 9).

We investigated 373 novel, putative miRNAs that are exclusively present on the NCode Human miRNA microarray V3 (Invitrogen), and found that 194 of these exhibited significant temporal expression changes. Sequences were mapped to genomic hairpins and validated by qPCR with probes for the "mature" region. Subsequent bioinformatic analysis was performed using the miRDeep algorithm, which evaluates enrichment of sequence reads derived from the stem versus loop region of genomic hairpins, suggestive of miRNA processing [@pone.0060480-Friedlander1]. This analysis revealed that most of the small RNA sequences were unlikely to be classic miRNAs. By comparing expression profiles of various RNA size fractions, we determined that a significant proportion of the novel sequences were likely derived from larger non-coding RNAs. Several classes of ncRNA are dynamically regulated during development, and they may serve especially prominent roles in the developing brain (reviewed in [@pone.0060480-Amaral1]). For these reasons, all microarray features were retained for significance analysis, regardless of whether they represented miRNAs or other types of RNA. Model classes 1 (F\<Y = A) and 7 (F\<Y\<A) are comprised of 67 and 10 genes, respectively. Of these 77 genes with lowest expression during fetal stages, 74 are novel ncRNAs. From our RNA size fractionation experiments, 29 of the 312 genes with significant developmental changes in expression level were flagged as potentially being larger ncRNAs, and 26 of these flagged species were novel ncRNAs from either model class 1 (F\<Y\<A) or 3 (F = Y\<A). Taken together, these data implicate a class of longer ncRNAs that are progressively up-regulated during development and may serve important neurobiological functions in the adult brain.

TaqMan expression profiling was more sensitive than the glass-slide microarray technology which we used, and allowed us to examine trends within the prenatal and postnatal time points. Several miRNAs were identified which have noteworthy developmental expression patterns. For example, the mir-17-92 cluster on chromosome 13 and paralogue clusters on chromosome 7 and the X chromosome show decreasing expression throughout pre- and post-natal timepoints, consistent with a report in the porcine developing brain [@pone.0060480-Podolska1]. Mir-132 shows a marked increase in post-natal compared to pre-natal time points, and appears to increase throughout early childhood. In vivo experiments in the mouse hippocampus have implicated mir-132 in the maturation of excitatory synapses formed by newborn neurons [@pone.0060480-Luikart1], and mir-132 dysregulation has recently been implicated in schizophrenia [@pone.0060480-Miller1]. Mir-449a/b show a striking expression pattern during pre-natal development, with a peak of expression at week 17. Mir-449 has been shown to control ciliogenesis in the human airway epithelium [@pone.0060480-Marcet1], and has been proposed to regulate choroid plexus development based on expression patterns in the mouse brain [@pone.0060480-Redshaw1]. The peak in mir-449 expression at week 17 may be related to ciliogenesis in the ventricular system, which if impaired, can impact ion transport and cerebrospinal fluid production and flow [@pone.0060480-Banizs1].

In summary, we have established the first miRNA and non-coding RNA expression atlas of the developing human brain. Expression signatures varied significantly between fetal, early postnatal, and adult brain tissue samples, analogous to patterns of temporal regulation previously observed in animal model systems. Despite attempts to match samples with respect to demographic variables, factors pertaining to sample selection and handling can skew the results of post-mortem expression studies. Experimental and statistical methods were adopted to optimize sensitivity and accuracy of measured miRNA expression levels, yet some caveats still remain. The coronal sections of cerebrum from which RNA was extracted are heterogeneous in terms of cell type. Expression levels were averaged across multiple samples from a given developmental age to minimize regional effects, but the relative contribution of specific cellular populations to detected expression levels could conceivably vary across time points. Also, average post-mortem interval was higher for postnatal compared to prenatal samples ([**Table 1**](#pone-0060480-t001){ref-type="table"}), however our previous work demonstrates that few microRNAs (8%) have expression which is influenced by post-mortem interval [@pone.0060480-Moreau1]. Additionally, the pre- and postnatal sample set used is biased towards African-American individuals while the adult timepoints were from Caucasian individuals, which could conceivably confound results if there are large ethnic differences in microRNA expression in the brain. However, data from other tissues indicate that ethnic differences are likely to be modest [@pone.0060480-Huang1]. Despite these caveats, the valuable expression data presented here and the proposed classification scheme should guide future studies of miRNA expression and function in both normal and pathogenic development.
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